Atossa Therapeutics (ATOS) released a preliminary analysis from a phase 2 trial of (Z)-endoxifen as part of the I-SPY 2 Endocrine Optimization Pilot, EOP, will be the subject of a poster presentation ...

An international investigation team has completed a preliminary analysis of data from the black boxes of a Ukrainian passenger plane mistakenly shot down by Iran in January, the Transportation Safety ...

(Z)-endoxifen at 10 mg once daily met the primary endpoint with 19/20 (95%) receiving > 75 % of planned treatment in I-SPY-2 Phase 2 Trial Low dose (Z)-endoxifen was well tolerated and demonstrated ...

Preliminary data from the Southeast Regional Climate Center shows the Pioneer Valley had its driest fall on record, according to analysis from Michael Rawlins, the associated director of the ...

Homicides and serious assaults were down across Connecticut in 2024, including in Hartford where officials say they are the lowest they have been in about two decades, according to preliminary data.

BOSTON & MONTREAL--(BUSINESS WIRE)--enGene Holdings Inc. (Nasdaq: ENGN or “enGene” or the “Company”), is a clinical-stage genetic medicines company whose non-viral lead investigational product ...

GAINESVILLE, Fla.--(BUSINESS WIRE)--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing ...

Improving outcomes in high-grade goblet cell adenocarcinomas: The interplay of complete cytoreduction, HIPEC and fibrosis. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This ...

SHANGHAI and CHICAGO, June 4, 2025 /PRNewswire/ -- The 2025 ASCO Annual Meeting is taking place in Chicago, US, from May 30 to June 3. Duality Bio (HKEX: 9606.HK) presented the preliminary data of two ...

Verastem, Inc. (NASDAQ:VSTM) is one of the top long-term biotechnology stocks to buy. On October 23, Verastem, Inc. (NASDAQ:VSTM) reported positive preliminary results from an ongoing phase 1/2a ...